A major hallmark of cancer development, drug resistance and recurrent disease is the presence of genomic and epigenetic instability. Emphasis is on cancer defects in DNA repair, replication; centrosomes, heterochromatin and chromatin modifications.
Researchers
Anne Cress, PhD
Professor, Cellular and Molecular Medicine
Nathan Ellis, PhD
Associate Professor, Cellular and Molecular Medicine
Keith Maggert, PhD
Associate Professor, Cellular and Molecular Medicine
Justina McEvoy, PhD
Assistant Professor, Molecular and Cellular Biology
Greg Rogers, PhD
Associate Professor, Cellular and Molecular Biology
Cathy Smith, PhD
Associate Professor, Pharmacology & Toxicology
Eric Weterings, PhD
Associate Professor, Radiation Oncology
Guang Yao, PhD
Assistant Professor, Molecular and Cellular Biology